Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis
Rachel Rosovsky(Harvard University), Christopher Kabrhel(Harvard University), Ido Weinberg(Harvard University), Kenneth Rosenfield(Massachusetts General Hospital), Thoralf M. Sundt(Massachusetts General Hospital), Savannah Harshbarger(Harvard University), Alison S. Witkin(Harvard University), Yuchiao Chang(Harvard University), Josanna Rodriguez‐Lopez(Harvard University), Michael R. Jaff(Boston Scientific (United States)), Praveen Hariharan(Harvard University), Richard Channick(Harvard University), Blair A. Parry(Massachusetts General Hospital)
Cited by 165
Related Papers
Prevalence of Diagnosed Atrial Fibrillation in Adults
|JAMA|2001|6.2k
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up
|Journal of the American College of Cardiology|2020|2.9k
American Society of Hematology 2020 Guidelines for Management of Venous Thromboembolism: Treatment of Deep Vein Thrombosis and Pulmonary Embolism
|Blood Advances|2020|1.4k
Effect of Intensity of Oral Anticoagulation on Stroke Severity and Mortality in Atrial Fibrillation
|New England Journal of Medicine|2003|1.3k
The “Gender Gap” in Authorship of Academic Medical Literature — A 35-Year Perspective
|New England Journal of Medicine|2006|873